Overview
Jui-ling Hsu practices practicing medicine in Taoyuan, Taiwan.
Hsu is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer.
They are actively involved in clinical research, co-authoring 37 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jui-ling Hsu
Is Jui-ling Hsu a top-rated expert for Familial Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Jui-ling Hsu is classified as an Advanced expert for Familial Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jui-ling Hsu participate in research or clinical trials?
Yes. Jui-ling Hsu has published 37 articles and abstracts on conditions like Familial Prostate Cancer. You can view a list of Jui-ling Hsu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Prostate Cancer
- Experienced
- Lung CancerHsu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Prostate CancerHsu isExperienced. Learn about Prostate Cancer.